Cotización Quince Therapeutics - QNCX

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

1.575

Postura de Compra

1.57

Postura de Venta

1.58

Volume Operado de la Acción

79,941

1.55 Rango del Día 1.69

0.5116 Rango de 52 semanas 2.45

Capitalización de Mercado [m]

69.303M

Precio Anterior

1.67

Precio de Apertura

1.69

Hora

100

1.575

Última hora de negociación

14:14:50

Volumen financiero

US$ 128,039

Precio Promedio Ponderado

1.6017

Volumen promedio (3 m)

211,779

Acciones en circulación

44,001,643

Rendimiento del Dividendo

Ratio Precio/Utilidad

-2.73

Beneficio por acción (BPA)

-0.71

turnover

Beneficio neto

-31.39M

Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug ... Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patient's own red blood cells. Mostrar más

Sector

Biological Pds,ex Diagnstics

Industria

Biological Pds,ex Diagnstics

Sitio web

quincetx.com

Sede

Wilmington, Delaware, USA

Fundado

Quince Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker QNCX. The last closing price for Quince Therapeutics was US$1.67. Over the last year, Quince Therapeutics shares have traded in a share price range of US$ 0.5116 to US$ 2.45.

Quince Therapeutics currently has 44,001,643 shares in issue. The market capitalisation of Quince Therapeutics is US$73.48 million. Quince Therapeutics has a price to earnings ratio (PE ratio) of -2.73.

Quince Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that...

Quince Therapeutics Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia

Allowance to extend into 2036 patent claims related to method of treating patients with A-T using the company’s proprietary EryDex process Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage...

Quince Therapeutics to Host Investor Webinar on February 7, 2025 Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that...

Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, announced the online...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.065	-3.96341463415	1.64	1.69	1.49	92495	1.60879512	CS
4	-0.325	-17.1052631579	1.9	1.97	1.4001	135287	1.65662482	CS
12	0.0044	0.280147714249	1.5706	2.45	1.4001	211779	1.86779076	CS
26	0.875	125	0.7	2.45	0.5116	383727	1.30553953	CS
52	0.245	18.4210526316	1.33	2.45	0.5116	233004	1.24115469	CS
156	-4.185	-72.65625	5.76	6.8	0.5116	427418	1.70795902	CS
260	-48.625	-96.8625498008	50.2	121.98	0.5116	458272	13.06323943	CS

QNCX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Quince Therapeutics?

El precio actual de las acciones de Quince Therapeutics es US$ 1.575

¿Cuántas acciones de Quince Therapeutics están en circulación?

Quince Therapeutics tiene 44,001,643 acciones en circulación

¿Cuál es la capitalización de mercado de Quince Therapeutics?

La capitalización de mercado de Quince Therapeutics es USD 73.48M

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Quince Therapeutics?

Quince Therapeutics ha negociado en un rango de US$ 0.5116 a US$ 2.45 durante el último año

¿Cuál es el ratio PE (precio/beneficio) de Quince Therapeutics?

El ratio precio/beneficio de Quince Therapeutics es -2.73

¿Cuál es la moneda de reporte de Quince Therapeutics?

Quince Therapeutics presenta sus resultados financieros en USD

¿Cuál es el último beneficio anual de Quince Therapeutics?

El último beneficio anual de Quince Therapeutics es USD -31.39M

¿Cuál es la dirección registrada de Quince Therapeutics?

La dirección registrada de Quince Therapeutics es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

¿Cuál es la dirección del sitio web de Quince Therapeutics?

La dirección del sitio web de Quince Therapeutics es quincetx.com

¿En qué sector industrial opera Quince Therapeutics?

Quince Therapeutics opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
LTRYLottery com Inc	US$ 1.3562 (176.83%)	232.66M
QNTMQuantum Biopharma Ltd	US$ 16.0501 (87.06%)	33.99M
APPSDigital Turbine Inc	US$ 4.6478 (82.98%)	105.26M
LIPOLipella Pharmaceuticals Inc	US$ 4.5608 (76.78%)	84.45M
MSPRMSP Recovery Inc	US$ 2.78 (57.06%)	9.78M
BTAIBioXcel Therapeutics Inc	US$ 0.1852 (-38.04%)	8.07M
SDASunCar Technology Group Inc	US$ 5.265 (-37.62%)	4.22M
RETOReTo Eco Solutions Inc	US$ 0.5148 (-35.65%)	691.08k
SRTSSensus Healthcare Inc	US$ 5.90 (-34.37%)	2.59M
AVGRAvinger Inc	US$ 0.3869 (-30.90%)	1.19M
MGOLMGO Global Inc	US$ 0.174 (25.18%)	317.92M
LTRYLottery com Inc	US$ 1.355 (176.59%)	232.67M
NVDANVIDIA Corporation	US$ 127.53 (2.16%)	194.38M
CYNCYNGN Inc	US$ 0.0823 (0.37%)	126.37M
RIMEAlgorhythm Holdings Inc	US$ 0.0216 (3.35%)	112.5M